U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07377006) titled 'Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer' on Sept. 15, 2025.
Brief Summary: This clinical trial identifies factors associated with completing genetic testing, aids in the development of a decision support tool, and tests how well the decision support tool works to enhance germline genetic testing in patients with prostate cancer. Germline genetic testing is a guideline-recommended standard of care for many patients with prostate cancer. Completing genetic testing can enable the use of targeted therapies, offers access to novel clinical trials, provides valuable information, and can ...